Found 2 hits of ec50 for monomerid = 50277084 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50277084
![PNG](/data/jpeg/tenK5027/BindingDB_50277084.png) (CHEMBL4160347)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C147H222N44O47S2/c1-68(2)48-91(128(221)171-90(43-47-240-11)127(220)178-97(55-109(153)203)137(230)190-115(72(8)196)118(154)211)173-131(224)96(53-78-59-162-83-29-19-18-28-81(78)83)177-126(219)89(39-42-108(152)202)172-143(236)114(70(5)6)189-135(228)94(50-75-24-14-12-15-25-75)176-132(225)98(56-111(205)206)179-125(218)88(38-41-107(151)201)166-119(212)71(7)165-122(215)85(31-22-45-160-146(155)156)167-123(216)86(32-23-46-161-147(157)158)169-140(233)103(64-194)185-134(227)100(58-113(209)210)180-129(222)92(49-69(3)4)174-142(235)105(66-239)187-124(217)84(30-20-21-44-148)168-139(232)102(63-193)184-130(223)93(52-77-33-35-80(199)36-34-77)175-133(226)99(57-112(207)208)181-141(234)104(65-195)186-145(238)117(74(10)198)191-136(229)95(51-76-26-16-13-17-27-76)182-144(237)116(73(9)197)188-110(204)61-163-121(214)87(37-40-106(150)200)170-138(231)101(62-192)183-120(213)82(149)54-79-60-159-67-164-79/h12-19,24-29,33-36,59-60,67-74,82,84-105,114-117,162,192-199,239H,20-23,30-32,37-58,61-66,148-149H2,1-11H3,(H2,150,200)(H2,151,201)(H2,152,202)(H2,153,203)(H2,154,211)(H,159,164)(H,163,214)(H,165,215)(H,166,212)(H,167,216)(H,168,232)(H,169,233)(H,170,231)(H,171,221)(H,172,236)(H,173,224)(H,174,235)(H,175,226)(H,176,225)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,234)(H,182,237)(H,183,213)(H,184,223)(H,185,227)(H,186,238)(H,187,217)(H,188,204)(H,189,228)(H,190,230)(H,191,229)(H,205,206)(H,207,208)(H,209,210)(H4,155,156,160)(H4,157,158,161)/t71-,72+,73+,74+,82-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,114-,115-,116-,117-/m0/s1 | PDB MMDB
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description Agonist activity at human GCGR expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046 BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this Ligand-Target Pair | |
Glucagon-like peptide 1 receptor
(Homo sapiens (Human)) | BDBM50277084
![PNG](/data/jpeg/tenK5027/BindingDB_50277084.png) (CHEMBL4160347)Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O |r| Show InChI InChI=1S/C147H222N44O47S2/c1-68(2)48-91(128(221)171-90(43-47-240-11)127(220)178-97(55-109(153)203)137(230)190-115(72(8)196)118(154)211)173-131(224)96(53-78-59-162-83-29-19-18-28-81(78)83)177-126(219)89(39-42-108(152)202)172-143(236)114(70(5)6)189-135(228)94(50-75-24-14-12-15-25-75)176-132(225)98(56-111(205)206)179-125(218)88(38-41-107(151)201)166-119(212)71(7)165-122(215)85(31-22-45-160-146(155)156)167-123(216)86(32-23-46-161-147(157)158)169-140(233)103(64-194)185-134(227)100(58-113(209)210)180-129(222)92(49-69(3)4)174-142(235)105(66-239)187-124(217)84(30-20-21-44-148)168-139(232)102(63-193)184-130(223)93(52-77-33-35-80(199)36-34-77)175-133(226)99(57-112(207)208)181-141(234)104(65-195)186-145(238)117(74(10)198)191-136(229)95(51-76-26-16-13-17-27-76)182-144(237)116(73(9)197)188-110(204)61-163-121(214)87(37-40-106(150)200)170-138(231)101(62-192)183-120(213)82(149)54-79-60-159-67-164-79/h12-19,24-29,33-36,59-60,67-74,82,84-105,114-117,162,192-199,239H,20-23,30-32,37-58,61-66,148-149H2,1-11H3,(H2,150,200)(H2,151,201)(H2,152,202)(H2,153,203)(H2,154,211)(H,159,164)(H,163,214)(H,165,215)(H,166,212)(H,167,216)(H,168,232)(H,169,233)(H,170,231)(H,171,221)(H,172,236)(H,173,224)(H,174,235)(H,175,226)(H,176,225)(H,177,219)(H,178,220)(H,179,218)(H,180,222)(H,181,234)(H,182,237)(H,183,213)(H,184,223)(H,185,227)(H,186,238)(H,187,217)(H,188,204)(H,189,228)(H,190,230)(H,191,229)(H,205,206)(H,207,208)(H,209,210)(H4,155,156,160)(H4,157,158,161)/t71-,72+,73+,74+,82-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,114-,115-,116-,117-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
China Pharmaceutical University
Curated by ChEMBL
| Assay Description Agonist activity at full length human GLP1R expressed in HEK293 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay |
Eur J Med Chem 138: 1158-1169 (2017)
Article DOI: 10.1016/j.ejmech.2017.07.046 BindingDB Entry DOI: 10.7270/Q2QC061V |
More data for this Ligand-Target Pair | |